Cardiac Resynchronization Therapy Defibrillators (CRT-Ds), Compia MRI. Labeled as the following: a. Compia MRI CRT-D DF1 (Product No. DTMC1D1); b. Compia MRI Quad CRT-D DF4 (Product No.DTMC1QQ ) Implantable devices that automatically detect and treat episodes of ventricular fibrillation, ventricular
Check against the official notice below — it lists the full affected range.
Medtronic Inc. is recalling 951 Compia MRI Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices distributed nationwide in the United States. These devices may fail to deliver high and low voltage therapy, which are critical functions for treating abnormal heart rhythms in patients who have had these implantable devices placed.
The specific affected devices include the Compia MRI CRT-D DF1 (Product No. DTMC1D1 with UDI 00643169705807 and serial number RPW200289H) and Product No. DTMC1QQ (UDI 00643169565272) with multiple associated serial numbers. The recall document does not specify what action affected consumers should take in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
Possible prevention of high and low voltage therapy in Medtronic Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillator (CRT-D).
Reason for recall: Possible prevention of high and low voltage therapy in Medtronic Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillator (CRT-D). Distribution: US Nationwide Distribution. Quantity: 951 devices total Lot/code info: a. Product No. DTMC1D1: UDI 00643169705807 (Serial No. RPW200289H); b. Product No. DTMC1QQ: UDI 00643169565272 (Serial No. RPL201034H) (EXPANSION: Serial No. RPL200052H, RPL200534H, RPL201039H, RPL201059H, RPL201235H, RPL201236H, RPL201454H, RPL201645H, RPL201664H, RPL201234H)
Official record: FDA (Device enforcement) ↗
Republished from the official source above; details can change — the source record controls.